methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate

C22H37N3O4+2 — CID 8997792

IUPACmethyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate
SMILESCC[C@@H](C)[C@H](NC(=O)C[NH+]1CC[NH+](Cc2cc(C)ccc2OC)CC1)C(=O)OC
InChIInChI=1S/C22H35N3O4/c1-6-17(3)21(22(27)29-5)23-20(26)15-25-11-9-24(10-12-25)14-18-13-16(2)7-8-19(18)28-4/h7-8,13,17,21H,6,9-12,14-15H2,1-5H3,(H,23,26)/p+2/t17-,21+/m1/s1
InChIKeyAOAJJSYDNXZCMG-UTKZUKDTSA-P
MW407.56 g/mol
LogP-1.01
Rot. Bonds9

About methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate

methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate (PubChem CID 8997792) has the molecular formula C22H37N3O4+2 and a molecular weight of 407.56 g/mol. Its IUPAC name is methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate.

Molecular Properties

Compound Namemethyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate
PubChem CID8997792
Molecular FormulaC22H37N3O4+2
Molecular Weight407.56 g/mol
Exact Mass407.28
IUPAC Namemethyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate
SMILESCC[C@@H](C)[C@H](NC(=O)C[NH+]1CC[NH+](Cc2cc(C)ccc2OC)CC1)C(=O)OC
InChIInChI=1S/C22H35N3O4/c1-6-17(3)21(22(27)29-5)23-20(26)15-25-11-9-24(10-12-25)14-18-13-16(2)7-8-19(18)28-4/h7-8,13,17,21H,6,9-12,14-15H2,1-5H3,(H,23,26)/p+2/t17-,21+/m1/s1
InChIKeyAOAJJSYDNXZCMG-UTKZUKDTSA-P
XLogP-1.01
TPSA73.51 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds9
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500407.56
LogP ≤ 5-1.01
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Analyze methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate?
The IUPAC name of methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate (CID 8997792) is methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate.
What is the SMILES notation for methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate?
The canonical SMILES for methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate is CC[C@@H](C)[C@H](NC(=O)C[NH+]1CC[NH+](Cc2cc(C)ccc2OC)CC1)C(=O)OC.
What is the InChIKey of methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate?
The InChIKey is AOAJJSYDNXZCMG-UTKZUKDTSA-P. The full InChI is InChI=1S/C22H35N3O4/c1-6-17(3)21(22(27)29-5)23-20(26)15-25-11-9-24(10-12-25)14-18-13-16(2)7-8-19(18)28-4/h7-8,13,17,21H,6,9-12,14-15H2,1-5H3,(H,23,26)/p+2/t17-,21+/m1/s1.
What are the key properties of methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate?
methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate has a molecular weight of 407.56 g/mol, XLogP of -1.01, 9 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for methyl (2S,3R)-2-[[2-[4-[(2-methoxy-5-methylphenyl)methyl]piperazine-1,4-diium-1-yl]acetyl]amino]-3-methylpentanoate is sourced from PubChem (CID 8997792), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).